Totally implantable venous catheters for chemotherapy: experience in 500 patients
- PMID: 15543368
- PMCID: PMC11126163
- DOI: 10.1590/s1516-31802004000400003
Totally implantable venous catheters for chemotherapy: experience in 500 patients
Abstract
Context: Totally implantable devices are increasingly being utilized for chemotherapy treatment of oncological patients, although few studies have been done in our environment to analyze the results obtained from the implantation and utilization of such catheters.
Objective: To study the results obtained from the implantation of totally implantable catheters in patients submitted to chemotherapy.
Type of study: Prospective.
Setting: Hospital do Cancer A.C. Camargo, Sao Paulo, Brazil.
Methods: 519 totally implantable catheters were placed in 500 patients submitted to chemotherapy, with preference for the use of the right external jugular vein. Evaluations were made of the early and late-stage complications and patient evolution until removal of the device, death or the end of the treatment.
Results: The prospective analysis showed an average duration of 353 days for the catheters. There were 427 (82.2%) catheters with no complications. Among the early complications observed, there were 15 pathway hematomas, 8 cases of thrombophlebitis of the distal stump of the external jugular vein and one case of pocket infection. Among the late-stage complications observed, there were 43 infectious complications (0.23/1000 days of catheter use), 11 obstructions (0.06/1000 days of catheter use) and 14 cases of deep vein thrombosis (0.07/1000 days of catheter use). Removal of 101 catheters was performed: 35 due to complications and 66 upon terminating the treatment. A total of 240 patients died while the catheter was functioning and 178 patients are still making use of the catheter.
Conclusion: The low rate of complications obtained in this study confirms the safety and convenience of the use of totally implantable accesses in patients undergoing prolonged chemotherapy regimes.
CONTEXTO:: Os dispositivos totalmente implantáveis vêm sendo cada vez mais utilizados para quimioterapia de pacientes oncológicos, porém poucos são os estudos em nosso meio que analisam os resultados obtidos com a implantação e utilização desses cateteres.
OBJETIVO:: Estudar os resultados obtidos com a implantação de cateteres totalmente implantáveis em pacientes submetidos a quimioterapia.
TIPO DO ESTUDO:: Prospectivo.
LOCAL:: Hospital do Câncer A.C. Camargo, São Paulo, Brasil.
MÉTODOS:: Foram colocados 519 cateteres totalmente implantáveis em 500 pacientes a serem submetidos a regime de quimioterapia preferencialmente utilizando-se a veia jugular externa direita. Foram avaliadas as complicações precoces, as tardias e a evolução até a retirada do dispositivo, morte ou fim de tratamento.
RESULTADOS:: A análise prospectiva mostrou duração média dos cateteres de 353 dias. Em 427 (82,2%) cateteres não se observou nenhuma complicação. Entre as complicações precoces, observamos 15 hematomas de trajeto, oito tromboflebites de coto distal de veia jugular externa e uma infecção de bolsa de subcutâneo. Entre as complicações tardias, observamos 43 complicações infecciosas (0,23/1000 dias de uso de cateter), 11 obstruções (0,06/1000 dias de uso de cateter) e 14 tromboses venosas profundas (0,07/1000 dias de uso de cateter). Foram retirados 101 cateteres, 35 devido às complicações e 66 por final de tratamento. 240 pacientes foram a óbito com o cateter funcionante e 178 pacientes ainda o utilizavam para quimioterapia.
CONCLUSÃO:: As baixas taxas de complicação obtidas nesse estudo confirmam a segurança e conveniência do uso dos acessos totalmente implantáveis em pacientes em regime prolongado de quimioterapia.
Conflict of interest statement
Similar articles
-
Totally implantable femoral vein catheters in cancer patients.Eur J Surg Oncol. 2004 Sep;30(7):771-5. doi: 10.1016/j.ejso.2004.05.019. Eur J Surg Oncol. 2004. PMID: 15296992
-
Implantation of central venous ports with catheter insertion via the right internal jugular vein in oncology patients: single center experience.Support Care Cancer. 2006 Nov;14(11):1162-5. doi: 10.1007/s00520-006-0073-2. Epub 2006 Apr 5. Support Care Cancer. 2006. PMID: 16596418
-
Clinical review and analysis of complications of totally implantable venous access devices for chemotherapy.Med Oncol. 2012 Jun;29(2):1361-4. doi: 10.1007/s12032-011-9887-y. Epub 2011 Mar 6. Med Oncol. 2012. PMID: 21380779
-
Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman.Sultan Qaboos Univ Med J. 2021 Feb;21(1):e103-e109. doi: 10.18295/squmj.2021.21.01.014. Epub 2021 Mar 15. Sultan Qaboos Univ Med J. 2021. PMID: 33777430 Free PMC article. Review.
-
Complications associated with the use of Port-a-Caths in patients with malignant or haematological disease: a single-centre prospective analysis.Eur J Cancer Care (Engl). 2010 Sep;19(5):676-81. doi: 10.1111/j.1365-2354.2009.01115.x. Epub 2009 Aug 25. Eur J Cancer Care (Engl). 2010. PMID: 19708941 Review.
Cited by
-
Risk factors for complications in cancer patients with totally implantable access ports: A retrospective study and review of the literature.J Int Med Res. 2019 Feb;47(2):702-709. doi: 10.1177/0300060518808167. Epub 2018 Nov 15. J Int Med Res. 2019. PMID: 30442047 Free PMC article. Review.
-
Systematic review: malfunction of totally implantable venous access devices in cancer patients.Support Care Cancer. 2011 Jul;19(7):883-98. doi: 10.1007/s00520-011-1171-3. Epub 2011 May 10. Support Care Cancer. 2011. PMID: 21556721
-
Outcome analysis in 3,160 implantations of radiologically guided placements of totally implantable central venous port systems.Eur Radiol. 2011 Jun;21(6):1224-32. doi: 10.1007/s00330-010-2045-7. Epub 2011 Jan 5. Eur Radiol. 2011. PMID: 21207035
-
Central line bundle including split-septum device and single-use prefilled flushing syringes to prevent port-associated bloodstream infections: a cost and resource-utilization analysis.BMC Health Serv Res. 2020 Apr 21;20(1):336. doi: 10.1186/s12913-020-05221-6. BMC Health Serv Res. 2020. PMID: 32316939 Free PMC article.
-
Incidence and risk factors of infectious complications related to implantable venous-access ports.Korean J Radiol. 2014 Jul-Aug;15(4):494-500. doi: 10.3348/kjr.2014.15.4.494. Epub 2014 Jul 9. Korean J Radiol. 2014. PMID: 25053910 Free PMC article.
References
-
- Broviac JW, Cole JJ, Scribner BH. A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet. 1973;136(4):602–606. - PubMed
-
- Hickman RO, Buckner CD, Clift RA, Sandres JE, Stewart P, Thomas ED. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet. 1979;148(6):871–875. - PubMed
-
- Gyves JW, Ensminger WD, Niederhuber JE, et al. A totally implanted injection port system for blood sampling and chemotherapy administration. JAMA. 1984;251(19):2538–2541. - PubMed
-
- Freytes CO, Reid P, Smith KL. Long-term experience with a totally implanted catheter system in cancer patients. J Surg Oncol. 1990;45(2):99–102. - PubMed
-
- Carde P, Cosset-Delaigue MF, Laplanche A, Chareau I. Classical external indwelling central venous catheter versus totally implanted venous access systems for chemotherapy administration: a randomized trial in 100 patients with solid tumors. Eur J Cancer Clin Oncol. 1989;25(6):939–944. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials